UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000041493 |
|---|---|
| Receipt number | R000047323 |
| Scientific Title | A multi-institutional, retrospective, translational study of the relationship between histological immune-related signatures and clinical benefit of paclitaxel + bevacizumab therapy in HER2-negative advanced breast cancer |
| Date of disclosure of the study information | 2020/09/01 |
| Last modified on | 2021/07/14 15:20:16 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2020/08/21 09:22:26 | ||
| 2 | Update | 2020/08/31 14:44:17 | Date of IRB |
|
| 3 | Update | 2021/02/22 13:09:04 | Recruitment status Anticipated trial start date Last follow-up date |
|
| 4 | Update | 2021/07/14 15:17:57 | Number of participants that the trial has enrolled |
|
| 5 | Update | 2021/07/14 15:20:16 | Recruitment status |
